Results from Enestgoal: A Phase 2 Study of Treatment-Free Remission (TFR) in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Switched from Imatinib to Nilotinib

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Ritchie, EK; Catchatourian, R; Klisovic, RB; Pinilla-Ibarz, J; Deininger, MW; Erba, HP; Radich, JP; Savona, MR; Dautaj, I; Purkayastha, D; Habucky, K; Mauro, MJ

Published Date

  • December 7, 2017

Published In

Volume / Issue

  • 130 /

Published By

Pages

  • 3

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 59th Annual Meeting of the American-Society-of-Hematology (ASH)

Conference Location

  • Atlanta, GA

Conference Start Date

  • December 9, 2017

Conference End Date

  • December 12, 2017